300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Bolivia
Faroe Islands
Jersey
Bahrain
Estonia
Belize
Bahamas
Italy
Belarus
Finland
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
BHARAT V. DAFTARY, Chairman & Managing Director at Bharat Serums and Vaccines

BHARAT V. DAFTARY

Chairman & Managing Director @ Bharat Serums and Vaccines

Mumbai, India

BHARAT V. DAFTARY is a private equity investor at Bharat Serums and Vaccines in Mumbai focused on Medical and Health Care. Mr. Bharat V. Daftary, Chairman and Managing Director of the Company, has been involved with the business affairs of the Company since over three decades. He plays an important role in the marketing function and in development of global relationships. He spearheads the strategic planning of the Company. He is related to Dr. Gautam Daftary, ViceChairman and Managing Director of the Company and Mr. Siddharth B. Daftary, Whole-time Director of the Company

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries BHARAT V. DAFTARY invests in

MedicalHealth CareBiotechnologyHealth Diagnostics

Stages BHARAT V. DAFTARY invests in

Private Equity

Countries BHARAT V. DAFTARY invests in

India

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (100%)
  • Health Care 1 (100%)
  • Biotechnology 1 (100%)
  • Health Diagnostics 1 (100%)

Investments

CompanyDescriptionRoundLinks
Rivaara Labs Rivaara Labs
Rivaara Labs offers molecular diagnostics services and various clinical testing solutions. The company is dedicated to the establishment of a large network of specialized Molecular Diagnostics labs, a best-in-class national reference lab, and the marketing of novel Point Of Care (POC) solutions. Its solutions address a significant unmet medicalneed for timely, actionable information that addresses the challenges of the current standard of care for diagnosing and monitoring diseases. Rivaara Labs' open, dynamic, and collaborative culture enables teams to deliver innovation to healthcare professionals and patients. $7.3M / Private Equity / Nov 07, 2022

Co-Investors

Bharat Serums and Vaccines

About Bharat Serums and Vaccines

VC Fund · Mumbai, India

Bharat Serums and Vaccines is a biopharmaceutical company focused on creating innovative treatments in women's health and critical care. The company offers a diverse range of products, including plasma derivatives and monoclonal antibodies, aimed at addressing various medical conditions. With a strong emphasis on research and development,Bharat Serums and Vaccines strives to enhance accessibility and improve patient outcomes globally.

Bharat Serums and Vaccines Contacts

NameEmailPhoneSocials
BHARAT V. DAFTARY
BHARAT V. DAFTARY Chairman & Managing Director
Chirag Mehta
Chirag Mehta Chief Financial Officer
Gautam Daftary
Gautam Daftary Vice Chairman & Managing Director
Nilesh Kulkarni
Nilesh Kulkarni Chief Human Resource Officer
Rahul Adakmol
Rahul Adakmol COO (International Operations & Business Development)

Sign up to unlock verified contacts

Unlock Contacts

See all contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Retail
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Bolivia
Faroe Islands
Jersey
Bahrain
Estonia
Belize
Bahamas
Italy
Belarus
Finland
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does BHARAT V. DAFTARY invest in?

BHARAT V. DAFTARY invests primarily in Medical, Health Care and Biotechnology startups, most often at Private Equity stage. Most of the 1 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact BHARAT V. DAFTARY?

Public channels for BHARAT V. DAFTARY include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did BHARAT V. DAFTARY last invest?

The most recent investment recorded for BHARAT V. DAFTARY closed in Nov 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
BHARAT V. DAFTARY BHARAT V. DAFTARY Find email